Cognitive Protective Effect of Newer Antidiabetic Drugs
Condition: Type 2 Diabetes Interventions: Drug: Dapagliflozin; Drug: Empagliflozin; Drug: Canagliflozin; Drug: Sitagliptin; Drug: Saxagliptin; Drug: Linagliptin; Drug: Vildagliptin Sponsor: Alexandria University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canagliflozin | Dapagliflozin | Diabetes | Empagliflozin | Endocrinology | Forxiga | Invokana | Januvia | Jardiance | Research